Murtaza Ahmed

Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma

Amin H. Nassar, Chul Kim, Tolulope Tosin Adeyelu, Elias Bou Farhat et autres

Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rare, aggressive lung tumor marked by significant molecular heterogeneity. In a study of 590 patients across two independent cohorts, we observe comparable overall survival across treatment regimens (chemotherapy, chemoimmunotherapy, immunotherapy) without unexpected adverse events. …

us, no, es, be, de, it, gb (code pays fourni par la source)

Integrated Molecular and Clinical Characterization of Pulmonary Large Cell Neuroendocrine Carcinoma

Anne C. Chiang, Amin H. Nassar, Chul Kim, Tolulope Tosin Adeyelu et autres

us, in, be, de, it, gb, es (code pays fourni par la source)

A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy

Murtaza Ahmed, Brent K. Larson, Arsen Osipov, Nilofer A. Azad et autres

// Murtaza Ahmed 1 , Brent K. Larson 2 , Arsen Osipov 3 , Nilofer Azad 4 and Andrew Hendifar 3 1 Department of Internal Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA 2 Department of Pathology and Laboratory Medicine, …

us (code pays fourni par la source)

Neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (PDAC) with germline DNA damage repair (DDR) mutations: A dual institution retrospective study.

Murtaza Ahmed, Marco Ventin, Giulia Cattaneo, Arya Shahrzad et autres

4164 Background: Neoadjuvant approaches are routinely used in the treatment of resectable, borderline resectable (BR) and locally advanced (LA) PDAC. However, there are few predictive biomarkers of response to neoadjuvant therapy in potentially resectable PDAC patients. Mutations in DDR genes occur frequently …

us (code pays fourni par la source)

Comparison of chemotherapy to chemo-immunotherapy as first-line treatment in patients with advanced large cell neuroendocrine carcinomas (LCNECs) of mixed histology: A multi-institutional international retrospective study.

Kelsey Matteson, Amin H. Nassar, Timothy Ellis-Caleo, Emanuele Claudio Mingo et autres

8602 Background: LCNECs are a rare subtype of lung cancer, with limited clinical trial data and an unclear consensus on first-line treatment. Even less is known about the optimal treatment approach for pts with mixed LCNECs, a pathologic subtype where tumors contain …

us, it, be, es, gb (code pays fourni par la source)

Affect on Survival Per Increase in Each Millimeter of Tumor Depth in Tongue Cancer

Sandhya Gokavarapu, Murtaza Ahmed, Nagendra Parvataneni, K. V. V. N. Raju et autres

in (code pays fourni par la source)

Reliability of MRI in measuring tongue tumour thickness: a 1.5T study.

Usman Bashir, Muhammad Usman Manzoor, Yasir Majeed, Rizwan Ullah Khan et autres

BACKGROUND: Tongue tumour thickness has been shown to have a correlation with neck nodal metastasis and hence patient survival. Current AJCC guidelines recommend inclusion of tongue tumour thickness measurement in routine radiologic staging. Several studies have attempted to define the accuracy of …

pk (code pays fourni par la source)